annual cash & cash equivalents:
$114.09M+$64.79M(+131.40%)Summary
- As of today (June 17, 2025), MLYS annual cash & cash equivalents is $114.09 million, with the most recent change of +$64.79 million (+131.40%) on December 31, 2024.
- During the last 3 years, MLYS annual cash & cash equivalents has risen by +$103.48 million (+975.11%).
- MLYS annual cash & cash equivalents is now at all-time high.
Performance
MLYS Cash and cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly cash & cash equivalents:
$165.01M+$50.92M(+44.63%)Summary
- As of today (June 17, 2025), MLYS quarterly cash & cash equivalents is $165.01 million, with the most recent change of +$50.92 million (+44.63%) on March 31, 2025.
- Over the past year, MLYS quarterly cash & cash equivalents has increased by +$74.59 million (+82.49%).
- MLYS quarterly cash & cash equivalents is now at all-time high.
Performance
MLYS quarterly cash & cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash and cash equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
MLYS Cash and cash equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +131.4% | +82.5% |
| 3 y3 years | +975.1% | - |
| 5 y5 years | +7997.3% | +1454.9% |
MLYS Cash and cash equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +975.1% | at high | +237.1% |
| 5 y | 5-year | at high | +7997.3% | at high | +1454.9% |
| alltime | all time | at high | +7997.3% | at high | +1454.9% |
MLYS Cash and cash equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $165.01M(+44.6%) |
| Dec 2024 | $114.09M(+131.4%) | $114.09M(+17.3%) |
| Sep 2024 | - | $97.27M(+43.4%) |
| Jun 2024 | - | $67.86M(-25.0%) |
| Mar 2024 | - | $90.42M(+83.4%) |
| Dec 2023 | $49.30M | $49.30M(-42.9%) |
| Sep 2023 | - | $86.30M(-14.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2023 | - | $101.14M(-26.8%) |
| Mar 2023 | - | $138.25M(+57.6%) |
| Dec 2022 | $87.70M(+726.4%) | $87.70M(+79.1%) |
| Sep 2022 | - | $48.95M(+361.3%) |
| Dec 2021 | $10.61M(+653.2%) | - |
| Dec 2021 | - | $10.61M |
| Dec 2020 | $1.41M | - |
FAQ
- What is Mineralys Therapeutics annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Mineralys Therapeutics?
- What is Mineralys Therapeutics annual cash & cash equivalents year-on-year change?
- What is Mineralys Therapeutics quarterly cash & cash equivalents?
- What is the all time high quarterly cash & cash equivalents for Mineralys Therapeutics?
- What is Mineralys Therapeutics quarterly cash & cash equivalents year-on-year change?
What is Mineralys Therapeutics annual cash & cash equivalents?
The current annual cash & cash equivalents of MLYS is $114.09M
What is the all time high annual cash & cash equivalents for Mineralys Therapeutics?
Mineralys Therapeutics all-time high annual cash & cash equivalents is $114.09M
What is Mineralys Therapeutics annual cash & cash equivalents year-on-year change?
Over the past year, MLYS annual cash & cash equivalents has changed by +$64.79M (+131.40%)
What is Mineralys Therapeutics quarterly cash & cash equivalents?
The current quarterly cash & cash equivalents of MLYS is $165.01M
What is the all time high quarterly cash & cash equivalents for Mineralys Therapeutics?
Mineralys Therapeutics all-time high quarterly cash & cash equivalents is $165.01M
What is Mineralys Therapeutics quarterly cash & cash equivalents year-on-year change?
Over the past year, MLYS quarterly cash & cash equivalents has changed by +$74.59M (+82.49%)